Ian Michael Estepan Sarepta Therapeutics, Inc. (SRPT) insider trading activity

SRPT Quotes by TradingView

Ian Michael Estepan is Chief Financial Officer of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 54,336 shares of SRPT, which is worth approximately $2.92 Million. The most recent transaction as insider was on Mar 04, 2022, when has been sold 1,308 shares (Common Stock) at a price of $79.2 per share, resulting in proceeds of $103,594. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54.3K
61.25% 3M change
50.25% 12M change
Total Value Held $2.92 Million

Ian Michael Estepan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2022
SELL
Payment of exercise price or tax liability
$103,594 $79.2 p/Share
1,308 Reduced 4.96%
25,069 Common Stock
Mar 01 2022
SELL
Payment of exercise price or tax liability
$28,219 $75.05 p/Share
376 Reduced 1.41%
26,377 Common Stock
Sep 08 2021
SELL
Payment of exercise price or tax liability
$127,065 $78.29 p/Share
1,623 Reduced 5.72%
26,753 Common Stock
Mar 03 2021
BUY
Grant, award, or other acquisition
-
15,000 Added 34.06%
29,042 Common Stock
IME

Ian Michael Estepan

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRPT